Teva Pharmaceutical Industries Limited · TASE:TEVA
Teva Pharmaceutical Industries — JPMorgan Healthcare Conference 2015
8 slides from Teva Pharmaceutical Industries's conference presentation, Jan 13, 2015
Slide 1: Transforming Teva
1 Transforming Teva January 13, 2015 Erez Vigodman, President & CEO
Slide 2: Our Must Wins for Transforming Teva
2 2 Our Must Transforming Wins for Teva 2014 Drive organic growth Maintain COPAXONE® franchise Solidify the foundation
Slide 3: Teva's 4 Levers of Organic Growth
Teva’s 4 Levers of Organic Growth ILLUSTRATIVE 3 3 (Under the Scenario of Copaxone® Generic Competition Starting Sept 2015) Generics Cost Reduction Existing Specialty Specialty Pipeline EPS ($) Deliver on the Promise in our Specialty Pipeline 5.00 Manage the Life Cycle of Key Specialty Products Exec
Slide 4: Teva's 4 Levers of Organic Growth
Teva’s 4 Levers of Organic Growth ILLUSTRATIVE 4 4 (Under the Scenario of Copaxone® Generic Competition Starting Jan 1, 2015) Generics Cost Reduction Existing Specialty Specialty Pipeline EPS ($) 5.00 FY14 FY15 FY16 FY17 FY18 FY19
Slide 5: Ample Resources for Business Development
5 Ample Resources for Business Development 5 Teva’s robust cash flow generation and strong balance sheet position create ample liquidity for business development activities in all sizes $m 60% 14.7 16 4,500 4,300-4,700 12.2 14 50% 39% 10.6 12 3,700 3,500-3,900 40% 35% 9.3 31% 10 30% 27% 8 3,237 6 20
Slide 6: Value Creation Beyond Organic Growth
Value Creation Beyond Organic Growth 6 6 Transforming Teva Significant potential for Business additional value creation Development Drive organic growth Maintain COPAXONE® franchise Solidify the foundation
Slide 7: Targeting a Unique Space in the Industry
7 Transforming Teva 7 Targeting a Unique Space In The Industry Strategic focus on Where to play Most Competitive Differentiated core capabilities decision global operational integrated R&D and organic platform with growth highest quality standards Beyond chemical Strong market Global leadership Stro
Slide 8: Thank You
Te i Thank You OO
Teva Pharmaceutical Industries — JPMorgan Healthcare Conference 2015 on 6ix